AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
2426
DELISTED
PROS Holdings
PRO
| $683K | ﹤0.01% |
31,750
+6,400
| +25% | +$146K |
|
|
IMMU
2427
DELISTED
Immunomedics Inc
IMMU
| $681K | ﹤0.01% |
185,498
| – | – |
|
|
BKS
2428
DELISTED
Barnes & Noble
BKS
| $681K | ﹤0.01% |
61,110
| – | – |
|
2429
Flotek Industries
FTK
$852M
| $678K | ﹤0.01% |
12,033
-1,167
| -9% | -$85.2K |
|
2430
StoneX
SNEX
$9.26B
| $678K | ﹤0.01% |
86,619
| – | – |
|
|
TRTN
2431
DELISTED
Triton International Limited
TRTN
| $676K | ﹤0.01% |
42,800
| – | – |
|
2432
Chegg
CHGG
$110M
| $675K | ﹤0.01% |
91,400
+18,700
| +26% | +$139K |
|
|
JUNO
2433
DELISTED
Juno Therapeutics, Inc.
JUNO
| $675K | ﹤0.01% |
35,826
-660
| -2% | -$16.1K |
|
|
PIR
2434
DELISTED
Pier 1 Imports, Inc.
PIR
| $674K | ﹤0.01% |
3,946
-1,027
| -21% | -$119K |
|
2435
Fox Factory Holding Corp
FOXF
$755M
| $672K | ﹤0.01% |
24,200
+6,900
| +40% | +$165K |
|
2436
AeroVironment
AVAV
$7.56B
| $670K | ﹤0.01% |
24,971
| – | – |
|
2437
MGP Ingredients
MGPI
$379M
| $670K | ﹤0.01% |
13,400
+500
| +4% | +$22.2K |
|
2438
ING
ING
$99.8B
| $667K | ﹤0.01% |
47,335
-43,192
| -48% | -$582K |
|
2439
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $664K | ﹤0.01% |
30,100
+10,700
| +55% | +$203K |
|
2440
Inovio Pharmaceuticals
INO
$55.7M
| $663K | ﹤0.01% |
7,967
| – | – |
|
2441
Wingstop
WING
$3.53B
| $663K | ﹤0.01% |
22,400
+5,500
| +33% | +$162K |
|
|
ORBC
2442
DELISTED
ORBCOMM, Inc.
ORBC
| $663K | ﹤0.01% |
80,200
| – | – |
|
2443
AtriCure
ATRC
$1.92B
| $661K | ﹤0.01% |
33,800
| – | – |
|
2444
Virtu Financial
VIRT
$5.11B
| $660K | ﹤0.01% |
41,400
-403,896
| -91% | -$5.77M |
|
2445
iShares Russell Mid-Cap ETF
IWR
$56B
| $659K | ﹤0.01% |
14,736
-120
| -0.8% | -$5.25K |
|
|
CMCM
2446
Cheetah Mobile
CMCM
$86.6M
| $658K | ﹤0.01% |
13,774
+4,524
| +49% | +$240K |
|
|
EAD
2447
Allspring Income Opportunities Fund
EAD
$372M
| $658K | ﹤0.01% |
77,540
| – | – |
|
|
BKI
2448
DELISTED
Black Knight, Inc. Common Stock
BKI
| $658K | ﹤0.01% |
17,413
-102
| -0.6% | -$3.9K |
|
|
HAYN
2449
DELISTED
Haynes International, Inc.
HAYN
| $655K | ﹤0.01% |
15,233
+4,059
| +36% | +$161K |
|
2450
Home Federal Bancorp
HFBL
$71.3M
| $654K | ﹤0.01% |
48,726
-28,942
| -37% | -$357K |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.